PT-141
Explore a different approach to low sexual desire. Compounded prescription PT-141, with individualized clinician guidance and follow-up included.
A compounded three-part prescription for cases where vascular response may not be the only layer worth evaluating.
$149/month
Standard plan price$149 monthly.
The standard Sildenafil / Tadalafil / Oxytocin ODT price is $149 billed monthly. These are recurring prices before any eligible first-order discount. A first-order offer reduces that order only; renewal uses the standard price for the chosen plan.
A compounded three-part prescription for cases where vascular response may not be the only layer worth evaluating.
Read the evidence and its limitationsA licensed clinician reviews your health history and medications and determines whether treatment is appropriate for you.
Read the full Important Safety InformationComplete the online assessment with your health history, current medications and treatment goals. A licensed clinician reviews the information and decides whether to prescribe. If prescribed, a licensed pharmacy prepares and ships your medication.
See how care worksSildenafil and tadalafil are PDE5 inhibitors with decades of clinical use behind the drug class. They support penile blood flow in response to sexual stimulation. Their timing profiles differ, but they work through the same core vascular pathway.
Oxytocin is different. It is a hormone and neuropeptide involved in social and reproductive biology, and some prescribers include it in compounded sexual-health formulations. Here, it gives your clinician a separate connection and experience layer to evaluate alongside the vascular components.
The PDE5 components bring established vascular pharmacology, while oxytocin brings a distinct social and reproductive signal. Your clinician decides whether those ingredients belong together in your individual prescription.
The vascular components and the exploratory component do different jobs. Sildenafil and tadalafil carry the established blood-flow evidence; oxytocin gives the clinician a separate connection and experience question to evaluate.
Read the evidenceStandard single-agent therapy has already given your clinician useful information. You want the next decision based on that history rather than a generic escalation ladder.
You want to know which ingredients are supported by established clinical pharmacology and which are more exploratory. You want that difference stated plainly.
A compounded combination only interests you if a clinician can explain why this specific formulation belongs in your case.
Candidacy at these strengths is determined by a licensed provider from your full intake and your documented response, every time. This is not a formulation to escalate to on your own.
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
Strength describes the preparation. Total plan quantity is the amount included in that plan, not your dose or dosing schedule. Follow the directions on your prescription.
Compare billing options and longer-term costs
You'll begin an online assessment for Sildenafil / Tadalafil / Oxytocin ODT.
Starting an assessment doesn't guarantee a prescription. How care works
Prescription issued subject to provider judgment. Results vary. Not a guarantee of outcomes.
Your subscription renews at your selected billing interval. Cancel through your member dashboard before the next billing date to stop future charges. Cancellation does not refund the current billing period. See cancellation and refund terms.
Message your provider about dosing, side effects, your response or changes in your health.
Open patient portalNew to AnthologyRX? Ask our team about getting started.
Licensed clinicians affiliated with Arora Health & Aesthetics, LLC review your health history, medications and goals, then discuss whether Sildenafil / Tadalafil / Oxytocin ODT or another approach fits your needs.
Medical information on this page reviewed by Dr. Dylan Russell, MD, Chief Health Officer on . Your prescribing clinician provides your individual care.
Verify Dr. Russell's medical licensePrepared to your prescription by a licensed compounding pharmacy. Our partners have verified quality programs covering identity, potency, independent testing and batch documentation.
Compounded preparations are not FDA-approved. Pharmacy quality controls and your clinician's evaluation of treatment evidence each have a role in your care.
Availability depends on your prescription and location. For pharmacy questions, contact our team.
Message your provider through the patient portal about dosing, side effects, your response or changes in your health. Contact AnthologyRX support for billing, shipment or portal-access help.
The sildenafil evidence is registration-grade and it is single-agent. In two sequential double-blind studies, 532 men were randomized to sildenafil 25, 50 or 100 mg or placebo over 24 weeks and 329 different men entered a 12-week flexible dose-escalation study; in the last four weeks of the dose-escalation study, 69 percent of intercourse attempts succeeded on sildenafil versus 22 percent on placebo, with 5.9 versus 1.5 successful attempts per month.1
The tadalafil evidence is the same shape. In an integrated analysis of five randomized, double-blind, placebo-controlled 12-week trials in 1112 men of mean age 59, tadalafil 20 mg produced a mean 7.9 point improvement in the International Index of Erectile Function erectile-function domain, 75 percent of intercourse attempts were completed successfully on Sexual Encounter Profile question 3, and 81 percent reported improved erections versus 35 percent on placebo.2
At class level the record is large and it is still single-agent. A network meta-analysis of 82 randomized trials covering 47,626 patients compared PDE5 inhibitors against placebo and against one another, finding sildenafil 50 mg most efficacious with the highest overall adverse-event rate and tadalafil 10 mg intermediate in efficacy with the lowest. No trial in that analysis combined two of them.3
The oxytocin evidence that exists is mostly preclinical, and the review literature says so. A 2021 review traces a laboratory-animal literature dating to the 1980s in which central oxytocin facilitates erection and sexual behaviour in male and female animals, and then reports that the human studies, conducted mainly with intranasal oxytocin, do not appear to confirm that facilitatory role in either men or women.4
No trial has tested this three-ingredient tablet as sold. There is no published randomized trial of sildenafil, tadalafil and oxytocin given together for erectile dysfunction. The approved labeling for both PDE5 ingredients states that combinations with other PDE5 inhibitors or with other treatments for erectile dysfunction have not been studied and that such combinations are not recommended. The single-agent results above belong to the single agents and do not carry over.56
The human oxytocin studies in men did not show the thing the ingredient is usually sold for. In a double-blind, placebo-controlled crossover experiment in 10 healthy men, 24 international units of intranasal oxytocin raised plasma oxytocin and epinephrine but did not alter appetitive, consummatory or refractory sexual behaviour on the scale used. In 29 heterosexual couples, 58 participants, the same intranasal dose did not alter sexual drive, arousal, penile erection or lubrication; the effects that did appear were on orgasm intensity, contentment after intercourse and partner interaction, with small to moderate effect sizes.78
The longest randomized oxytocin trial in sexual dysfunction was negative. In a 22-week randomized, double-blind, placebo-controlled crossover trial in 30 premenopausal and postmenopausal women with sexual dysfunction, intranasal oxytocin 32 international units taken before intercourse raised Female Sexual Function Index scores by 26 percent while placebo raised them by 31 percent, with no significant treatment, sequence or interaction effect.9
The route studied is not the route sold. Every human sexual-function study cited here used intranasal oxytocin, and the FDA-approved oxytocin products are sterile injections given by intravenous infusion or intramuscular injection for obstetric indications, not for sexual function. No controlled trial establishes what an orally disintegrating oxytocin dose does. The tablet itself is compounded to an individual prescription, is not an FDA-approved drug product, and has not been through a trial programme of its own.78910
The PDE5 ingredients carry most of what people report, and all of those effects appear in approved labeling. Your provider reviews nitrates, riociguat, alpha-blockers, other blood-pressure medication and cardiovascular history before prescribing. Oxytocin is the least settled part of the formulation for this purpose: FDA-approved oxytocin products are injections used under obstetric supervision, and their labeling documents an antidiuretic effect. The three-ingredient tablet itself is compounded to your individual prescription by a licensed 503A pharmacy and is not an FDA-approved drug product. A licensed clinician decides whether each component earns its place at the start, and keeps deciding at follow-up.
Explore a different approach to low sexual desire. Compounded prescription PT-141, with individualized clinician guidance and follow-up included.
A clinician-guided compounded oxytocin nasal spray for people exploring the social and emotional layer of intimacy.
A clinician-selected compounded rapid-dissolve tablet that brings two familiar timing profiles into one individualized prescription.
You are in
CODEEnter it at checkout for 20% off your first order. Keep it handy.
Find your treatmentBrowse all treatments